Mrosovsky, N
Boehringer Ingelheim describes it as a dual glucagon/GLP1 receptor agonist that has the potential to address obesity while also supporting liver function, a key regulator of metabolic health. The company links the waistcircumference reduction in SYNCHRONIZE1 to effects on visceral fat, noting that excess visceral fat, particularly abdominal, is a known contributor to metabolic dysfunction and closely connected to impaired liver function
This hormone helps the body release insulin when blood sugar rises, while also reducing the release of glucagon, a hormone that raises blood sugar
This can be hard to do with diet and exercise, which is why more and more women are asking their doctors about taking GLP-1 medications postpartum
The fastest route for most people is a telehealth provider like TrimRx, where you complete an online consultation, receive a prescription, and have medication shipped directly to your home without an in-person visit
Optimize your Testosterone